richmondpharmacology.com Report : Visit Site

Technical data of the richmondpharmacology.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host richmondpharmacology.com. Currently, hosted in United Kingdom and its service provider is Webfusion Internet Solutions .

the related websites

trials4us.co.uk workatrichmondpharmacology.co.uk weekendnotes.co.uk literacytrust.org.uk walmart.com nhs.uk kirkpatrickandhopes.com tradermade.com fsmitha.com bilderberg.org welshjournals.llgc.org.uk internationalwomensday.com 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called nginx containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

-- blank space -- +44 (0) 20 7042 5800 8:00am to 7:00pm - mon to fri work with our experts, get in touch » toggle navigation home (current) about us about us what makes us special? mission statement meet the experts brochures websites videos case studies our services our services specalist services adaptive phase i studies tqt studies bridging studies patient recruitment full services protocol writing & crf design regulatory applications data management pharmacy laboratory drug free plasma in house volunteer catering news news -- latest news archive upcoming events events publications knowledge base contact us we are currently migrating to our new website. please check back shortly. -- welcome to richmond pharmacology reliable and experienced full-service provider in early phase trial management watch our video work with us work with our experts and conduct your trial in a cost effective and timely manor get a quote -- adaptive phase i & ii from first-time-in-human to proof of concept we provide competent peer to peer interaction learn more -- adaptive phase i & ii from first-time-in-human to proof of concept we provide competent peer to peer interaction learn more adaptive phase i & ii from first-time-in-human to proof of concept we provide competent peer to peer interaction learn more -- bridging studies cost effective, time efficient and safe protocol design. over 60 bridging studies delivered on schedule since our founding bridging studies thorough & intensive qtc studies from advice by renowned experts to competent study conduct and ecg analysis. all under one roof tqt studies patient recruitment recognised for our fast and efficient recruitment. our database has over 250,000 active potential participants find out more our reputation has been gained through the successful conduct of over 300 early phase studies since inception in 2001, ranging from testing a naesthetic agents to z inamide interaction studies. the specialist areas in which we have really excelled over many years are adaptive, thorough-qt, japanese bridging studies and patient recruitment – evident in the numerous peer-reviewed papers we have published. uk's leading clinical research organisation our business ethos is unique: our revenues serve the national health service and st george’s university of london, fund basic research, support charities or otherwise are reinvested in the business. our business is sustainable, adaptive to change and is led by the same specialists who founded the business more than ten years ago. all our sponsors are preferred clients. richmond pharmacology’s interaction with its sponsors is personal and truly strategic, generating enhanced value for drug developers and investors. our work is closely supervised throughout by the same senior specialists sponsors meet during the first consultation or bid defence. our services span strategic consultancy and concept development through to final reporting, utilising our many years of experience and leading to successful clinical trials with meaningful results. more about us adaptive phase i & iia bridging studies tqt studies patient recruitment richmond pharmacology's people have extensive knowledge and expertise. view our latest peer-reviewed publications. we are committed to publishing data from all our clinical trials. learn more about richmond pharmacology by viewing some of our videos. work with our experts conduct your trial in a cost effective and timely manner get in touch today subscribe to richmond pharmacology latest headlines, publications and events delivered to your inbox we'll never spam or give this address away subscribe -- latest news upcoming event officially an ils resuscitation council course centre 07th mar 2018 richmond pharmacology’s london bridge unit is now officially an ils resuscitation council course centre. the read more › dr jorg taubel attending accp in san diego 05th sep 2017 dr jorg taubel will be attending the accp in san diego, september 17-19, where he will be discussing his latest read more › dia, chicago 2017 23rd jun 2017 richmond pharmacology is a frequent contributor and recognised thought leader for various scientific meetings read more › upcoming event dia global annual meeting 24th jun 2018 we will be attending the dia 2018 | boston ma come and visit us at booth #1020 at the boston covention & view event › inotrem successfully completes its first phase i clinical trial with motrem™, a trem-1 pathway modulator for the treatment of septic shock 21st september 2016 paris, france, september 13, 2016 – inotrem sa, a biotechnology company specializing in the control of acute inflammatory syndromes, such as septic shock, announced today the successful completion of the first clinical trial of motrem in healthy volunteers. read more › -- futura medical plc announce headline results from its efficacy study of the company's novel gel for the treatment of erectile dysfunction 11th november 2016 the study comprised a total of 232 randomised males and it measured, as its primary endpoint, improvement in the erectile function ("ef") domain score of the international index of erectile function ("iief"), the scoring system used for the approval of pde5 inhibitors such as viagra®. read more › -- no triumph without trials 24th februray 2016 in the last 70 years, the development of clinical cancer research has been remarkable. from the discovery of the first form of effective chemotherapy in 1949 to the genetically tailored cancer drugs of the 90s, treatment methods have evolved dramatically in the modern era thanks to decades of rigorous clinical trials. with the help of some of the world’s leading oncologists and cancer treatment specialists we’ve decided to produce a timeline which outlines 10 of the most important advances in clinical cancer. read more › -- © 2017 richmond pharmacology | upcoming events | jobs | corporate accounts | disclaimer | sitemap | privacy policy clinical trials london --

URL analysis for richmondpharmacology.com

http://www.richmondpharmacology.com/disclaimer
http://www.richmondpharmacology.com/about/
http://www.richmondpharmacology.com/about/videos
http://www.richmondpharmacology.com/about/brochures
http://www.richmondpharmacology.com/specialist-services/adaptive-phase-i-studies.php
http://www.richmondpharmacology.com/case-studies/
http://www.richmondpharmacology.com/full-services/
http://www.richmondpharmacology.com/contact/
http://www.richmondpharmacology.com/archive/
http://www.richmondpharmacology.com/full-services/laboratory
http://www.richmondpharmacology.com/events/
http://www.richmondpharmacology.com/news/dr-jorg-taubel-attending-accp-in-san-diego
http://www.richmondpharmacology.com/full-services/catering
http://www.richmondpharmacology.com/about/mission-statement
http://www.richmondpharmacology.com/specialist-services/
workatrichmondpharmacology.co.uk

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: RICHMONDPHARMACOLOGY.COM
Registry Domain ID: 76211467_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.totalregistrations.com
Registrar URL: http://www.totalregistrations.com
Updated Date: 2017-08-21T07:24:40Z
Creation Date: 2001-08-20T15:50:19Z
Registry Expiry Date: 2018-08-20T15:50:14Z
Registrar: Total Web Solutions Limited trading as TotalRegistrations
Registrar IANA ID: 131
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +44.8448475838
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS0.UKFAST.NET
Name Server: NS1.UKFAST.NET
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2017-08-27T18:25:07Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR Total Web Solutions Limited trading as TotalRegistrations

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =richmondpharmacology.com

  PORT 43

  TYPE domain

DOMAIN

  NAME richmondpharmacology.com

  CHANGED 2017-08-21

  CREATED 2001-08-20

STATUS
clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited

NSERVER

  NS0.UKFAST.NET 81.201.128.133

  NS1.UKFAST.NET 81.201.143.133

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .